L3VLUP
ProSign in

TWST in the 13F filings

Twist Bioscience Corp · CUSIP 90184D100

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
14 Feb 2024
latest of these filings; the earliest 17 Jan 2024
Managers listing it
5
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 5 listed it in both
Shares listed
12,926,187
combined, among listed positions
Reported value
$476m
combined, at the quarter end

Among the 93 comparable managers: 3 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing TWST in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

5 of 5 holders

ActionFiling
ARK Investment Management LLC7,213,257$266m1.57%Added+427,27417 Jan 2024 (the filing on sec.gov)
Artisan Partners LP3,723,305$137m0.21%Added+1,961,62112 Feb 2024 (the filing on sec.gov)
Baillie Gifford & Co1,094,758$40munder 0.1%Trimmed-173,53726 Jan 2024 (the filing on sec.gov)
Voloridge Investment Management LLC770,188$28m0.11%Added+35,34714 Feb 2024 (the filing on sec.gov)
PDT Partners LLC124,679$4.6m0.51%Held014 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
6 in Q3 2024 to 10 in Q2 2026

Tracked managers listing it, at least.

03581020192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TWST by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20181$2.3mn.a.n.a.
Q1 20191$1.7mn.a.n.a.
Q2 20194$30mn.a.n.a.
Q3 20192$6.8mn.a.n.a.
Q4 20194$26mn.a.n.a.
Q1 20204$67mn.a.n.a.
Q2 20205$127mn.a.n.a.
Q3 20209$726mn.a.n.a.
Q4 202010$1.9bnn.a.n.a.
Q1 202110$1.7bnn.a.n.a.
Q2 20219$1.8bnn.a.n.a.
Q3 20217$1.1bnn.a.n.a.
Q4 20213$739mn.a.n.a.
Q1 20225$601mn.a.n.a.
Q2 20224$324mn.a.n.a.
Q3 20225$343mn.a.n.a.
Q4 20226$247mn.a.n.a.
Q1 20235$142mn.a.n.a.
Q2 20235$220mn.a.n.a.
Q3 20236$294mn.a.n.a.
Q4 20235$476m31
Q1 20245$468m23
Q2 20249$758m64
Q3 20246$594m15
Q4 20246$620m24
Q1 20257$579m42
Q2 20256$547m41
Q3 20254$405m30
Q4 20254$465m1116
Q1 20268$794m198
Q2 202610$1.8bn1715

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

TWST and GILD →TWST and AMGN →TWST and ARGX →Choose a stock to compare with TWST →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TWST, latest filings →Back to the 13F Explorer →